Achieved YUTREPIA net product sales of $148.3 million for the full year 2025 with $90.1 million in the fourth quarterMore than 3,600 unique prescriptions received and 2,900 patients treated to date si ...
Learn about impairment loss, its impact on assets, and how it is calculated when market value falls below book value in financial statements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results